CAS 2207-75-2

Potassium oxonate

Description:

Potassium oxonate, with the CAS number 2207-75-2, is a chemical compound that serves primarily as a salt of oxonic acid. It is characterized by its white crystalline appearance and is soluble in water, which makes it useful in various applications, particularly in the pharmaceutical industry. The compound is known for its role as a uricosuric agent, which means it can help increase the excretion of uric acid in the urine, thus potentially aiding in the management of conditions like gout. In terms of its chemical structure, potassium oxonate contains potassium ions and oxonate anions, contributing to its ionic properties. It is important to handle this compound with care, as with any chemical substance, and to be aware of its potential effects and interactions in biological systems. Overall, potassium oxonate is a notable compound due to its therapeutic applications and its role in biochemical processes related to uric acid metabolism.

Formula: C₄H₂KN₃O₄

InChI: InChI=1/C4H3N3O4.K/c8-2(9)1-5-3(10)7-4(11)6-1;/h(H,8,9)(H2,5,6,7,10,11);/q;+1/p-1

InChI key: InChIKey=IXGSVCGUTCBYTE-UHFFFAOYSA-N

SMILES: C(O)(=O)C=1NC(=O)NC(=O)N1.[K]

Synonyms:

• 1,3,5-Triazine-2-carboxylic acid, 1,4,5,6-tetrahydro-4,6-dioxo-, monopotassium salt
• 1,3,5-Triazine-2-carboxylic acid, 1,4,5,6-tetrahydro-4,6-dioxo-, potassium salt (1:1)
• 1,4,5,6-Tetrahydro-4,6-Dioxo-S-Triazine-2-Carboxylicacid,Potassiumsalt
• 4,6-Dioxo-1,4,5,6-Tetrahydro-1,3,5-Triazine-2-Carboxylic Acid
• 5-Azaoroticacid,Potassiumsalt
• Allantoxanic Acid Potassium Salt
• Allantoxanic acid, monopotassium salt
• Labotest-Bb Lt00138090
• Oteracil Potassium
• Potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylate
• Potassium 2,6-dihydroxytriazinecarboxylate
• Potassium 4,6-Dihydroxy-1,3,5-Triazine-2-Carboxylate
• Potassium 4,6-Dioxo-1,4,5,6-Tetrahydro-1,3,5-Triazine-2-Carboxylate
• Potassium Allantoxanate
• Potassium Oxonate
• Potassium azaorotate
• Potassium otastat
• Potassium oxonate(OXO)
• Potassiumazaorotate
• kox
• 4,6-DIHYDROXY-1,3,5-TRIAZINE-2-CARBOXYLIC ACID, POTASSIUM SALT
• oxonic acid potassium
• （OXO）Oteracil potassium
• 4,6-Dihydroxy-1,3,5-triazine-2-carboxylic acid potassium salt, Allantoxanic acid
• Oteracil potassium(OXO)
• Oxonic acid, potassium salt, 97.50%
• POTASSIUMOXONATE/OTERACILPOTASSIUM
• OXONIC ACID POTASSIUM SALT 97.5%

Potassium Oxonate

CAS: 2207-75-2, 937-13-3

Formula: C₄H₂KN₃O₄

Purity: >98.0%(T)(HPLC)

Color and Shape: White to Almost white powder to crystal

Molecular weight: 195.18

Ref: 3B-O0164

Oxonic acid potassium salt

CAS: 2207-75-2

Inhibitor of uricase

Formula: C₄H₂KN₃O₄

Color and Shape: Powder, White to off-white

Molecular weight: 195.18

Ref: 02-J60400

POTASSIUM OXONATE

CAS: 2207-75-2

Formula: C₄H₂KN₃O₄

Purity: 95%

Color and Shape: Solid

Molecular weight: 195.1747

Ref: IN-DA003TWY

Oxonic Acid Potassium Salt

CAS: 2207-75-2

Formula: C₄H₂N₃O₄·K

Color and Shape: White To Off-White Solid

Molecular weight: 156.08 39.10

Ref: 4Z-O-042001

Potassium oxonate

CAS: 2207-75-2

Potassium oxonate

Purity: ≥98%

Molecular weight: 195.17g/mol

Ref: 54-BUP18679

Potassium Oxonate

CAS: 2207-75-2

Potassium Oxonate

Purity: 98%

Molecular weight: 195.17g/mol

Ref: 54-OR1014826

Oxonic Acid-13C2-15N3 Potassium Salt

CAS: 2207-75-2

Formula: C₂₁₃C₂H₂₁₅N₃O₄·K

Molecular weight: 161.04 39.10

Ref: 4Z-O-042003

Potassium oxonate

CAS: 2207-75-2

Potassium oxonate (Potassium azaorotate) is a uricase inhibitor that prevents metabolism and excretion of uric acid and induces embryotoxicity and

Formula: C₄H₂KN₃O₄

Purity: 98.55% - 99.86%

Color and Shape: Off-White Solid

Molecular weight: 195.17

Ref: TM-T5987

Oxonic Acid Potassium Salt

Controlled Product

CAS: 2207-75-2

Applications Antitumor effect potentiator and antitumor agent.
References Chelbova, et al.: Biochem. Pharmacol., 19, 1785 (1970), Collins, J., et al.: Clin. Pharmacol. Ther., 28, 235 (1980), Hoff, P., et al.: Anticancer Drugs, 9, 479 (1998), Backus, H., et al.: Oncol. Res., 12, 231(2000), Peters, G., et al.: J. Clin. Oncol., 19, 4267 (2001).

Formula: C₄H₂N₃O₄·K

Color and Shape: Neat

Molecular weight: 195.17

Ref: TR-O870060

Oxonic Acid -13C2,15N3 Potassium Salt Hydrate

Controlled Product

CAS: 2207-75-2, 855926-53-3

Applications Antitumor effect potentiator and antitumor agent.
References Chelbova, et al.: Biochem. Pharmacol., 19, 1785 (1970), Collins, J., et al.: Clin. Pharmacol. Ther., 28, 235 (1980), Hoff, P., et al.: Anticancer Drugs, 9, 479 (1998), Backus, H., et al.: Oncol. Res., 12, 231(2000), Peters, G., et al.: J. Clin. Oncol., 19, 4267 (2001),

Formula: C₂₁₃C₂H₂K₁₅N₃O₄•xH₂O

Color and Shape: Neat

Molecular weight: 218.161802

Ref: TR-O870062

Oxonic acid potassium

CAS: 2207-75-2

Oxonic acid potassium is a selectively competitive uricase inhibitor that avoids excretion of uric acid. It also inhibits the activity of orotate phosphoribosyltransferase (OPRT), an enzyme needed for the biosynthesis of pyrimidine nucleotides. Oxonic acid potassium catalyzes the phosphorylation of 5-fluorouracil (FF05372, BF166014) to 5-fluorouridine-5'-monophosphate (NF31487). In certain studies with rats, it has been shown that oxonic accid potassium suppresses the gastrointestinal toxicity of 5-fluorouracil or 5-FU without inhibiting the antitumor activity. Oxonic acid potassium, in combination with other prodrugs, boosts the antitumor activity and has shown positive results to treat gastric, pancreatic, lung, head, neck, and breast carcinomas.

Formula: C₄H₂KN₃O₄

Purity: Min. 98 Area-%

Color and Shape: Powder

Molecular weight: 195.17 g/mol

Ref: 3D-FO26698

Potassium oxonate

CAS: 2207-75-2

Formula: C₄H₂KN₃O₄

Purity: 95%

Color and Shape: Solid

Molecular weight: 195.175

Ref: 10-F210258

Oxonic Acid Potassium Salt

CAS: 2207-75-2

Formula: C₄H₂N₃O₄K

Molecular weight: 156.08 : 39.10

Ref: ST-EA-CP-O115004